1. Home
  2. AGNC vs RGEN Comparison

AGNC vs RGEN Comparison

Compare AGNC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AGNC Investment Corp.

AGNC

AGNC Investment Corp.

HOLD

Current Price

$10.34

Market Cap

10.7B

Sector

Real Estate

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$156.66

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGNC
RGEN
Founded
2008
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.7B
8.2B
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
AGNC
RGEN
Price
$10.34
$156.66
Analyst Decision
Buy
Buy
Analyst Count
10
10
Target Price
$10.16
$170.90
AVG Volume (30 Days)
20.4M
696.6K
Earning Date
01-26-2026
10-28-2025
Dividend Yield
13.95%
N/A
EPS Growth
N/A
N/A
EPS
0.70
0.03
Revenue
$956,000,000.00
$707,890,000.00
Revenue This Year
$8.02
$17.84
Revenue Next Year
$65.46
$12.57
P/E Ratio
$14.67
$6,185.26
Revenue Growth
N/A
11.74
52 Week Low
$7.85
$102.97
52 Week High
$10.67
$182.52

Technical Indicators

Market Signals
Indicator
AGNC
RGEN
Relative Strength Index (RSI) 49.63 47.50
Support Level $10.28 $160.11
Resistance Level $10.67 $165.02
Average True Range (ATR) 0.15 4.97
MACD -0.02 -1.27
Stochastic Oscillator 19.32 7.12

Price Performance

Historical Comparison
AGNC
RGEN

About AGNC AGNC Investment Corp.

AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: